HK1098356A1 - The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd - Google Patents
The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copdInfo
- Publication number
- HK1098356A1 HK1098356A1 HK07104757.8A HK07104757A HK1098356A1 HK 1098356 A1 HK1098356 A1 HK 1098356A1 HK 07104757 A HK07104757 A HK 07104757A HK 1098356 A1 HK1098356 A1 HK 1098356A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- anticholinergics
- glucocorticoids
- copd
- asthma
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54195604P | 2004-02-06 | 2004-02-06 | |
PCT/EP2005/000652 WO2005074918A1 (en) | 2004-02-06 | 2005-01-24 | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1098356A1 true HK1098356A1 (en) | 2007-07-20 |
Family
ID=34837533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07104757.8A HK1098356A1 (en) | 2004-02-06 | 2007-05-04 | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
Country Status (17)
Country | Link |
---|---|
US (2) | US20050175548A1 (el) |
EP (1) | EP1713473B1 (el) |
JP (1) | JP4819699B2 (el) |
CN (1) | CN100569235C (el) |
AU (1) | AU2005210085B2 (el) |
CA (1) | CA2551780C (el) |
DK (1) | DK1713473T3 (el) |
ES (1) | ES2413011T3 (el) |
HK (1) | HK1098356A1 (el) |
HR (1) | HRP20130460T1 (el) |
NO (1) | NO336882B1 (el) |
NZ (1) | NZ548300A (el) |
PL (1) | PL1713473T3 (el) |
PT (1) | PT1713473E (el) |
RU (1) | RU2440813C2 (el) |
SI (1) | SI1713473T1 (el) |
WO (1) | WO2005074918A1 (el) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
GB0523653D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
GB0523655D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
GB0523656D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
AU2006329042B2 (en) * | 2005-12-21 | 2012-02-02 | Meda Pharma Gmbh & Co Kg | Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
WO2009142589A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
ES2774391T3 (es) * | 2009-05-29 | 2020-07-20 | Pearl Therapeutics Inc | Composiciones, métodos y sistemas para la administración respiratoria de dos o más agentes activos |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
RU2561052C2 (ru) | 2009-12-23 | 2015-08-20 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Комбинированное лечение хронического обструктивного заболевания легких |
CN102665679B (zh) | 2009-12-23 | 2014-11-26 | 奇斯药制品公司 | 用于copd的联合治疗 |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
AU2013300009B2 (en) * | 2012-08-09 | 2017-06-15 | Chase Pharmaceuticals Corporation | Piperidinium quaternary salts |
EP3473615B1 (en) | 2013-02-28 | 2022-01-19 | Journey Medical Corporation | Glycopyrrolate salts |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
RU2696582C2 (ru) | 2013-03-15 | 2019-08-05 | Перл Терапьютикс, Инк. | Способы и системы кондиционирования дисперсных кристаллических материалов |
SG11201605311UA (en) | 2013-12-30 | 2016-07-28 | Chiesi Farma Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
CN113350352A (zh) | 2015-03-23 | 2021-09-07 | 墨尔本大学 | 呼吸性疾病的治疗 |
WO2016170518A1 (en) | 2015-04-24 | 2016-10-27 | Glenmark Specialty S.A. | Pharmaceutical compositions comprising arformoterol and glycopyrronium |
US10098837B2 (en) | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
RU2691110C2 (ru) * | 2017-11-20 | 2019-06-11 | Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) | Препарат для лечения заболеваний дыхательных путей у лошадей и способ его применения |
CN109498625B (zh) * | 2018-12-29 | 2021-04-16 | 温州医科大学附属第一医院 | 一种治疗慢性阻塞性肺疾病的药物组合物及其制备方法 |
IL293328A (en) | 2019-12-02 | 2022-07-01 | Chiesi Farm Spa | Stainless steel canister for pressurized metered dose inhalers |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100331255B1 (ko) * | 1993-07-02 | 2002-10-25 | 빅굴덴 롬베르그 케미쉐 화부리크 게엠베하 | 플루오로알콕시-치환된벤즈아미드및시클릭뉴클레오티드포스포디에스테라아제억제제로서의그의용도 |
US6204285B1 (en) * | 1996-07-01 | 2001-03-20 | Sepracor Inc. | Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate |
US6384038B1 (en) * | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
US6402285B1 (en) * | 1998-05-29 | 2002-06-11 | Citizen Watch Co., Ltd. | Method of subjecting ink jet printer to preuse treatment |
DE59904648D1 (de) * | 1998-08-04 | 2003-04-24 | Jago Res Ag Muttenz | Medizinische aerosolformulierungen |
CZ303154B6 (cs) * | 1998-11-13 | 2012-05-09 | Jagotec Ag | Suchá prášková formulace k inhalaci obsahující stearát horecnatý |
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
US6086914A (en) * | 1999-03-12 | 2000-07-11 | Weinstein; Robert E. | Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity |
US6203779B1 (en) * | 1999-03-19 | 2001-03-20 | Charlie Ricci | Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms |
US20040002548A1 (en) * | 1999-05-12 | 2004-01-01 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
DE19961300A1 (de) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
DE10007203A1 (de) * | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
DE10110772A1 (de) | 2001-03-07 | 2002-09-12 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren |
DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
GB0029903D0 (en) * | 2000-12-07 | 2001-01-24 | Arakis Ltd | Use of anti-muscarinic agents |
PL207377B1 (pl) | 2001-03-30 | 2010-12-31 | Jagotec Ag | Medyczny preparat aerozolowy, sposób wytwarzania medycznego preparatu aerozolowego oraz zastosowanie soli kwasów karboksylowych jako środków pomocniczych w tym preparacie |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
NZ529335A (en) | 2001-05-25 | 2005-09-30 | Pfizer | A PDE 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
ES2276942T3 (es) | 2001-05-25 | 2007-07-01 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Combinacion de un inhibidor de pde4 y tiotropio o un derivado del mismo para tratar vias respiratorias obstructivas y otras enfermedades inflamatorias. |
GB0118373D0 (en) | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Novel therapeutic method |
CN1422620A (zh) * | 2001-12-07 | 2003-06-11 | 中国人民解放军总装备部后勤部军事医学研究所 | 治疗氮氧化物中毒的气雾剂及其用途和制备方法 |
US7258118B2 (en) * | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
DE10216429A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittel enthaltend Steroide und ein neues Anticholinergikum |
US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
US20040038958A1 (en) * | 2002-07-11 | 2004-02-26 | Chris Rundfeldt | Topical treatment of skin diseases |
UA82323C2 (uk) | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань |
AU2003272450A1 (en) * | 2002-09-13 | 2004-04-30 | C. Steven Smith | Novel composition and method for treatment of upper respiratory conditions |
MXPA05010161A (es) | 2003-03-28 | 2005-11-16 | Altana Pharma Ag | Combinacion sinergistica que comprende roflumilast y un agente anticolinergico seleccionado a partir de sales de ipratropio, oxitropio y tiotropio para el tratamiento de enfermedades respiratorias. |
ATE384529T1 (de) * | 2003-03-28 | 2008-02-15 | Nycomed Gmbh | Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen |
CN100520419C (zh) * | 2003-07-11 | 2009-07-29 | Nxp股份有限公司 | 改进的频率确定 |
DE602005007708D1 (de) * | 2004-02-06 | 2008-08-07 | Meda Pharma Gmbh & Co Kg | Neue kombination von anticholinergen und beta mimetika zur behanldung von atemwegserkrankungen |
WO2005082413A2 (en) | 2004-02-27 | 2005-09-09 | Altana Pharma Ag | Ciclesonide and glycopyrronium combination |
AU2006329042B2 (en) * | 2005-12-21 | 2012-02-02 | Meda Pharma Gmbh & Co Kg | Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
-
2005
- 2005-01-24 SI SI200531713T patent/SI1713473T1/sl unknown
- 2005-01-24 NZ NZ548300A patent/NZ548300A/en unknown
- 2005-01-24 PT PT57069791T patent/PT1713473E/pt unknown
- 2005-01-24 AU AU2005210085A patent/AU2005210085B2/en not_active Ceased
- 2005-01-24 PL PL05706979T patent/PL1713473T3/pl unknown
- 2005-01-24 CA CA2551780A patent/CA2551780C/en not_active Expired - Fee Related
- 2005-01-24 RU RU2006132038/15A patent/RU2440813C2/ru not_active Application Discontinuation
- 2005-01-24 EP EP05706979A patent/EP1713473B1/en active Active
- 2005-01-24 CN CNB200580004060XA patent/CN100569235C/zh not_active Expired - Fee Related
- 2005-01-24 JP JP2006551763A patent/JP4819699B2/ja not_active Expired - Fee Related
- 2005-01-24 ES ES05706979T patent/ES2413011T3/es active Active
- 2005-01-24 DK DK05706979.1T patent/DK1713473T3/da active
- 2005-01-24 WO PCT/EP2005/000652 patent/WO2005074918A1/en active Application Filing
- 2005-02-07 US US11/051,468 patent/US20050175548A1/en not_active Abandoned
-
2006
- 2006-08-31 NO NO20063879A patent/NO336882B1/no not_active IP Right Cessation
-
2007
- 2007-05-04 HK HK07104757.8A patent/HK1098356A1/xx not_active IP Right Cessation
-
2008
- 2008-08-11 US US12/189,598 patent/US10537550B2/en active Active
-
2013
- 2013-05-24 HR HRP20130460TT patent/HRP20130460T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CN1913883A (zh) | 2007-02-14 |
NO336882B1 (no) | 2015-11-23 |
EP1713473B1 (en) | 2013-03-13 |
HRP20130460T1 (hr) | 2013-06-30 |
EP1713473A1 (en) | 2006-10-25 |
WO2005074918A1 (en) | 2005-08-18 |
SI1713473T1 (sl) | 2013-06-28 |
PL1713473T3 (pl) | 2013-08-30 |
RU2006132038A (ru) | 2008-03-20 |
ES2413011T3 (es) | 2013-07-15 |
CN100569235C (zh) | 2009-12-16 |
RU2440813C2 (ru) | 2012-01-27 |
NZ548300A (en) | 2010-04-30 |
AU2005210085B2 (en) | 2010-06-24 |
AU2005210085A1 (en) | 2005-08-18 |
JP2007520508A (ja) | 2007-07-26 |
US20080300226A1 (en) | 2008-12-04 |
US20050175548A1 (en) | 2005-08-11 |
PT1713473E (pt) | 2013-05-13 |
DK1713473T3 (da) | 2013-06-17 |
CA2551780C (en) | 2013-02-26 |
CA2551780A1 (en) | 2005-08-18 |
US10537550B2 (en) | 2020-01-21 |
NO20063879L (no) | 2006-11-01 |
JP4819699B2 (ja) | 2011-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130460T1 (hr) | Kombinacija antikolinergika i glukokortikoida za dugotrajno lijeäśenje astme i kroniäśne opstruktivne bolesti pluä†a (copd) | |
IL188730A0 (en) | Wound dressing and methods of making and using the same | |
IL181896A0 (en) | Methods and compositions for the treatment of hyperlipidemia | |
ZA200704718B (en) | Compositions and methods for reducing the transmissivity of illnesses | |
ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
PL1919450T3 (pl) | Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych | |
GB2434983B (en) | Methods and compositions for wound healing | |
IL189364A0 (en) | Estrogen compositions and therapeutic methods of use thereof | |
ZA200704677B (en) | Compositions and methods for the treatment of autism | |
GB2421571B (en) | Navigation apparatus and program of the same | |
EP1874286A4 (en) | METHOD AND COMPOSITIONS FOR TREATING ANXIETY STATE | |
IL178816A0 (en) | The treatment of childhood asthma | |
EP1729820A4 (en) | Impacted Membrane Bond Compounds and Methods of Use Therefor | |
ZA200703087B (en) | Methods and compositions for the treatment of hyperlipidemia | |
GB0411166D0 (en) | Treatment for asthma and arthritis | |
PT2380573E (pt) | Acetato de eslicarbazepina e métodos de utilização | |
HK1175117A1 (en) | Composition and method for the treatment of asthma symptoms | |
EP1720563A4 (en) | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION | |
EP1720893A4 (en) | COMPOSITIONS AND METHODS FOR SYSTEMIC TREATMENT OF ARTHRITIS | |
EP1945613A4 (en) | NOVEL 1-BENZYL-4-PIPERIDINAMINES FOR USE IN THE TREATMENT OF COPD AND ASTHMA | |
IL189248A0 (en) | Use of tiotropium salts in the treatment of severe persistant asthma | |
EP1737475A4 (en) | VEGETABLE THERAPY FOR THE TREATMENT OF ASTHMA | |
EP1937242A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISEASES AND ADDITIVES | |
IL181084A0 (en) | Process for the preparation of estrone and/or estradiol-derivates | |
ZA200805859B (en) | Methods and compositions for the treatment of gastriontestinal disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220126 |